Welcome to Xi’an Good Doctor Medical Science and Technology Co., Ltd.website ！
Internet Drug Information Service Qualification Certificate: (Shaanxi)-Non-Operating -2023-0143
2025-02-11
Objective: To explore the efficacy of continuous circulating hyperthermic intrathoracic chemotherapy at a constant temperature (42~43℃) for malignant pleural effusion.
2025-02-11
Comparison of the Efficacy of CCCHP and CHP in the Treatment of Malignant Effusion
Objective: To compare the efficacy of continuous circulating thermal perfusion chemotherapy (CCCHP) and thermal perfusion chemotherapy (CHP) in body cavities.
2025-02-11
Objective: To explore the efficacy of continuous circulating hyperthermic intraperitoneal chemotherapy at a constant temperature (42~43°C) for malignant ascites.
2025-02-11
Objective: To compare and analyze the effects of intraperitoneal hyperthermic perfusion chemotherapy and intraperitoneal perfusion chemotherapy in the treatment of colorectal cancer.
2025-02-11
Objective: To evaluate the efficacy and safety of chemotherapy combined with intraperitoneal hyperthermic perfusion in the treatment of malignant tumors with ascites.
· GDHIPEC from China ,
· Caring for Patients Worldwide ·
Address: Floor 1-2, Left Building No. 1, Huoju Road, East zone of Xi’an High- tech Development District, Xi’an, China
Copyright Xi'an Good Doctor Medical Technology Co., Ltd.
Internet Drug Information Service Qualification Certificate (Shaanxi)-Non-Operating -2023-0143